Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-32.04	12.10	17.81
Graham Fair Price	0.00	5.90	5.90
PEG	inf	0.00	0.46
Price/Book	1.24	0.81	0.80
Price/Cash Flow	1.24	10.24	10.12
Prices/Earnings	1.24	8.17	8.07
Price/Sales	1.24	3.38	3.34
Price/FCF	1.24	10.24	10.12
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	0.19	0.19
Operating Margin	0.00	0.12	0.12
ROA	0.00	0.01	0.01
ROE	0.02	0.02	0.00
ROIC	0.02	0.02	19.93
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.60	1.53	-60.60
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.02	0.00	inf
EPS QOQ	0.18	0.00	inf
FCF QOQ	4.15	0.00	inf
Revenue QOQ	0.12	0.00	inf
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.07	0.07	0.00
Days Sales Outstanding (DSO)	152.16	152.16	0.00
Inventory Turnover	1322.27	1322.27	0.00
Debt/Capitalization	0.27	0.13	-52.58
Quick Ratio	1.55	1.58	2.27
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	7.88	7.88	0.00
Cash	4.62	4.80	3.85
Capex	-0.04	-0.04	0.00
Free Cash Flow	0.63	0.63	0.00
Revenue	1.90	1.90	0.00
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.70	1.70	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-3.12	-9.09	-190.90
Naive Interpretation	Member

06 - Financial Health · Weak

Rating